2023 Germline EQA scheme registration closes in:

Webinar Series Now Available – Ensuring Accurate Classification of BRCA and HRR Variants (Run 9)

9 months ago

Thank you to all the participants who attended the webinar for the 2022 online individual assessment for classification of BRCA1, BRCA2 and other HRR gene variants (Run 9).

The webinar for run 9 of the Individual Variant Classification Assessment Scheme took place on the 23rd November 2022 where Dr. Simon Patton from EMQN, Professor Sandi Deans from GenQA (joint chairs) and an expert panel consisting of Professor Kathleen Claes (Center for Medical Genetics, University of Ghent, Belgium), Miranda Durkie (Department of Diagnostic Genetics, Sheffied Children’s NHS Foundation Trust) and Dr Maartje Vogel (Clinical Genetics Laboratory, Amsterdam UMC) discussed details of the results of the Individual Competency Assessment in addition to a summary of participant performance. Please see the webinar below:

These assessments are open to all individuals who classify the pathogenicity of BRCA and HRR gene variants and provides assurance of their competency to achieve this accurately and in the most up-to-date manner.

If you have any further questions, please contact GenQA at info@genqa.org or EMQN at office@emqn.org.

Next: Webinar Series Now Available - EGFR Liquid Biopsy EQA scheme for Lung Cancer Results Review & Laboratory Best Practice
Translate »